首页> 美国卫生研究院文献>Advanced Pharmaceutical Bulletin >Regenerative Medicine and Angiogenesis; Challenges and Opportunities
【2h】

Regenerative Medicine and Angiogenesis; Challenges and Opportunities

机译:再生医学和血管生成;挑战和机遇

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Blood vessel development is one of the most prominent steps in regenerative medicine due to the restoration of blood flow to the ischemic tissues and providing the rapid vascularization in clinical-sized tissue-engineered grafts. However, currently tissue engineering technique is restricted because of the inadequate in vitro/in vivo tissue vascularization. Some challenges like as transportation in large scale, distribution of the nutrients and poor oxygen diffusion limit the progression of vessels in smaller than clinically relevant dimensions as well in vivo integration. In this regard, the scholars attempted to promote the vascularization process relied on the stem cells (SCs), growth factors as well as exosomes and interactions of biomaterials with all of them to enable the emergence of ideal microenvironment which is needed for treatment of unhealthy organs or tissue regeneration and formation of new blood vessels. Thus, in the present review we aim to describe these approaches, advances, obstacles and opportunities as well as their application in regeneration of heart as a prominent angiogenesis-dependent organ.
机译:血管发育是由于恢复缺血组织的血液流动并在临床尺寸的组织工程移植物中提供快速血管形成,是再生医学中最突出的步骤之一。然而,目前由于体外/体内组织血管化的不足而受到限制。一些挑战是大规模的运输,营养素的分布和差的氧气扩散的分布限制了小于临床相关尺寸的血管的进展。在这方面,学者试图促进血管形成过程依赖于干细胞(SCS),生长因子以及生物材料的外来体和与所有人的相互作用,以实现理想的微环境,这是治疗不健康器官所需的理想微环境或组织再生和新血管的形成。因此,在本综述中,我们的目标是描述这些方法,进步,障碍和机会以及它们在重新生成作为突出的血管生成的器官的再生中的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号